Microanalytic Research, Inc.

Microanalytic Research, Inc. — FDA 510(k) Submissions

Microanalytic Research, Inc. has submitted 8 FDA 510(k) premarket notifications since 1980, of which 8 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Radioimmunoassay, Gentamicin (125-i), Second Antibody Sep., Radioimmunoassay, Tobramycin, Radioimmunoassay, Follicle-stimulating Hormone, Radioimmunoassay, Luteinizing Hormone, N-benzoyl-l-arginine Ethyl Ester (u.v.), Trypsin . Use the specialty filter in the sidebar to narrow results.